Persistent particles and monocyte/macrophage function

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

The project studies how a type of white blood cell interacts with damaged tissue at a site of inflammation, such as an occluded vessel or a brain plaque, and also with immunological adjuvants. It is believed that the nature of the material to be removed is critical in determining the effect on the white blood cell such that it can stay longer at the site and cause more damage or stimulate more immunity, respectively. The ultimate goal is to understand the cellular biochemistry responsible to help diseases, such as atherosclerosis and Alzheimer's disease, and to improve the quality of human adjuvants.

Funded Activity Details

Start Date: 01-01-2000

End Date: 01-01-2002

Funding Scheme: NHMRC Project Grants

Funding Amount: $356,232.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Pathology

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

CSF-1 | adjuvant | adjuvants | atherosclerosis; Alzheimer's disease | inflammation | inflammatory diseases | monocytes | phagocytosis